+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

Global Cancer Cachexia Market Report 2024 - Product Thumbnail Image

Global Cancer Cachexia Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Oncology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Oncology Clinical Trials - Global Strategic Business Report

  • Report
  • March 2025
  • 283 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • March 2025
  • 224 Pages
  • Global
From
From
Esophageal Cancer Market Report 2025 - Product Thumbnail Image

Esophageal Cancer Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Generic Oncology Sterile Injectable Market Report 2025 - Product Thumbnail Image

Generic Oncology Sterile Injectable Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Oncology Based in-Vivo CRO Market Report 2025 - Product Thumbnail Image

Oncology Based in-Vivo CRO Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more